Fuller & Thaler Asset Management Inc. Trims Stock Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Fuller & Thaler Asset Management Inc. decreased its position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 1.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,394,678 shares of the medical instruments supplier's stock after selling 17,966 shares during the quarter. ICU Medical makes up about 0.8% of Fuller & Thaler Asset Management Inc.'s holdings, making the stock its 23rd largest position. Fuller & Thaler Asset Management Inc. owned 5.70% of ICU Medical worth $216,412,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the company. Barclays PLC boosted its stake in shares of ICU Medical by 15.6% during the third quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier's stock worth $10,790,000 after buying an additional 8,010 shares during the period. Principal Financial Group Inc. lifted its position in ICU Medical by 24.6% in the third quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier's stock valued at $23,130,000 after purchasing an additional 25,031 shares during the period. Vanguard Group Inc. lifted its position in ICU Medical by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier's stock valued at $416,176,000 after purchasing an additional 17,805 shares during the period. Jennison Associates LLC acquired a new stake in ICU Medical in the fourth quarter valued at about $556,000. Finally, Franklin Resources Inc. lifted its position in ICU Medical by 99.3% in the third quarter. Franklin Resources Inc. now owns 11,708 shares of the medical instruments supplier's stock valued at $2,111,000 after purchasing an additional 5,834 shares during the period. Hedge funds and other institutional investors own 96.10% of the company's stock.

ICU Medical Price Performance

ICU Medical stock traded down $0.51 during trading hours on Monday, hitting $135.15. The stock had a trading volume of 114,853 shares, compared to its average volume of 273,395. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. ICU Medical, Inc. has a 1-year low of $95.44 and a 1-year high of $196.26. The stock's fifty day moving average is $143.81 and its two-hundred day moving average is $157.93. The stock has a market capitalization of $3.33 billion, a price-to-earnings ratio of -29.56 and a beta of 0.86.

Analyst Upgrades and Downgrades

ICUI has been the subject of a number of recent analyst reports. StockNews.com downgraded shares of ICU Medical from a "buy" rating to a "hold" rating in a research report on Thursday. Raymond James set a $97.00 price objective on shares of ICU Medical in a research report on Wednesday, March 12th. KeyCorp lowered their price target on ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. Two equities research analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, ICU Medical has a consensus rating of "Moderate Buy" and an average target price of $162.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.